Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 2006, p. 7155-7166, Vol. 26, No. 19
0270-7306/06/$08.00+0 doi:10.1128/MCB.00507-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
*
Andrew L. Singer,2,
,
David I. Hong,1
Berri H. Jacque,3
Martha S. Jordan,2
Maria-Cristina Seminario,4
Valarie A. Barr,1
Gary A. Koretzky,2 and
Lawrence E. Samelson1
Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland,1 Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania,2 Laboratory of Cellular and Molecular Biology, NIA, National Institutes of Health, Baltimore, Maryland,4 Program in Immunology, Tufts University School of Medicine, Boston, Massachusetts3
Received 22 March 2006/ Returned for modification 5 May 2006/ Accepted 11 July 2006
| ABSTRACT |
|---|
|
|
|---|
1, indicating that in the absence of a critical effector, these structures are insufficient to drive T-cell activation. Furthermore, we show that the critical adaptors LAT and Gads localize with SLP-76 in persistent clusters. Mutational analyses of LAT, Gads, and SLP-76 indicated that multiple domains within each of these proteins contribute to cluster persistence. These data indicate that multivalent cooperative interactions stabilize these persistent signaling clusters, which may correspond to the functional complexes predicted by kinetic proofreading models of T-cell activation. | INTRODUCTION |
|---|
|
|
|---|
Antigen-dependent signals are initiated at the interface between a T cell and an antigen-bearing APC. Frequently, the resulting immunological synapse is reorganized to generate a highly ordered structure characterized by the accumulation of the TCR, costimulatory proteins, and critical signaling molecules in a central domain bounded by adhesion molecules. This domain is referred to as a central supramolecular activation cluster (cSMAC), whereas the surrounding integrin-rich domain is referred to as a peripheral SMAC (pSMAC). Although the formation of a well-defined cSMAC often predicts effective T-cell activation, the cSMAC does not appear to correspond to the signaling complexes predicted by the kinetic proofreading model (19, 23, 53). First, the cSMAC gradually forms over 15 to 30 min in naive cells (29). Therefore, kinetic arguments preclude a role for the cSMAC in the discrimination of ligands with half-lives differing by seconds. Second, the cSMAC arises too late to drive the rapid changes in tyrosine phosphorylation, intracellular calcium, and cytoskeletal morphology that accompany synapse formation (18, 29, 39). Third, the mature cSMAC is not observed in several types of T cells or in response to certain stimuli (1, 20, 25, 40-42, 44). Finally, the cSMAC can contribute to the down-modulation of TCR-dependent signals (28, 30, 35). These observations indicate that decisive signaling events are independent of the cSMAC.
Modern imaging techniques have begun to reveal macromolecular signaling complexes induced by TCR ligation. These antigen-induced structures bridge the gap between the protein-protein interactions probed by classical biochemical analyses and higher-order structures, such as the cSMAC. TCR-rich microclusters 200 to 500 nm in diameter assemble within seconds of T-cell-APC contact (10, 12, 21, 26, 59). Our own dynamic imaging studies employing immobilized stimulatory antibodies have shown that these microclusters are the predominant sites of TCR-induced tyrosine phosphorylation and rapidly induce the coaccumulation of tyrosine kinases and critical adaptor proteins, such as SLP-76 (2, 6, 10). We refer to these macromolecular assemblies of signaling molecules as signaling clusters to distinguish them from the signaling complexes probed by traditional biochemical methods. Similar antigen receptor-based signaling clusters arise in T-cell lines, primary human T cells, and mast cells (2, 10, 50, 54, 55, 59). T cells responding to antigen-presenting lipid bilayers or to peptide-bearing APCs develop similar signaling clusters, confirming the relevance of these structures in vivo (12, 59). Critically, a single TCR microcluster is sufficient to induce intracellular calcium elevations, suggesting that individual signaling clusters are competent to initiate critical T-cell activation pathways (10).
The relationship between signaling clusters and the cSMAC is not well understood. In pMHC-induced synapses, TCR microclusters gradually coalesce to form a cSMAC (19, 27, 61). In contrast, signaling clusters containing the critical adaptor SLP-76 are observed in freshly initiated synapses but disappear at later times and fail to colocalize with the cSMAC (59). In the lipid bilayer model, TCR microclusters form in the periphery and move towards the center of the stimulatory interface. Microclusters containing the critical adaptor SLP-76 initially colocalize with the TCR and move towards the center of the contact with similar kinetics. However, the TCR accumulates in a central cluster that is largely devoid of phosphotyrosine, whereas SLP-76 disappears from these structures prior to its centralization (59). In our model system, TCR microclusters remain immobilized by the stimulating antibody but give rise to SLP-76-containing signaling clusters that segregate from the TCR and move towards the center of the stimulatory interface (10). These data indicate that the fates of TCR microclusters and SLP-76-containing signaling clusters diverge during T-cell activation.
Although the adaptor proteins LAT, Grb2, Gads, and SLP-76 cocluster with the TCR early in T-cell activation, relatively little is known about the formation and composition of SLP-76-containing signaling clusters (10, 15, 21). Lipid rafts may play a role in the initiation of signaling; nevertheless, protein-protein interactions appear to play the dominant role in the stabilization of these structures. Given the complexity of the potential interactions among the expected components of these clusters, complexes with diverse stoichiometries are theoretically possible. However, cooperative interactions among the components of these clusters may contribute to the avidities of specific complexes, ensuring that certain protein-protein interactions are favored in vivo and in vitro (6, 13, 22, 31, 62). In this manner, cooperative protein-protein interactions may contribute to the formation of persistent and functionally competent signaling clusters similar to those postulated by kinetic proofreading models.
In our current studies we demonstrate that persistent SLP-76-containing clusters move laterally within the immunological synapses induced by staphylococcal enterotoxin E (SEE), and we examine the properties of analogous SLP-76-containing structures in cells stimulated by immobilized antibodies. In particular, we (i) establish the genetic requirements for the assembly of persistent and mobile SLP-76-containing clusters, (ii) more fully characterize the compositions of these structures, and (iii) demonstrate that multivalent protein-protein interactions play unexpected and critical roles in the assembly and persistence of these structures. Finally, our observations indicate that the persistence of the SLP-76-containing signaling clusters is a decisive factor regulating T-cell activation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cell lines, transfections, and cell culture.
Parental E6.1 Jurkat T cells and Lck-deficient J.CaM1.6 Jurkat T cells were obtained from ATCC; LAT-deficient J.CaM2.5 Jurkat T cells and SLP-76-deficient J14 Jurkat T cells were gifts from Arthur Weiss (UCSF); and ZAP-70-deficient P116 Jurkat T cells and phospholipase C-
1 (PLC-
1)-deficient J
1 Jurkat T cells were gifts from Robert Abraham (Burnham Institute). Reconstituted variants of these cell lines were obtained from Arthur Weiss, Robert Abraham, and David Strauss (Medical College of Virginia) (52). Nalm-6 B cells were kindly provided by Ann Marie Pendergast (Duke University). J14 cell lines stably expressing wild-type and mutant EGFP.SLP-76 chimeras were either described previously or derived by identical means (49). The J14-derived line stably overexpressing SLP-76.YFP was also described previously (10). All cells were maintained as described previously (49). Cells used for transient transfections were maintained in RPMI 1640 supplemented with 10% fetal calf serum, glutamine (20 mM), and ciprofloxacin (10 µg/ml). Immediately prior to transfection, cells were rinsed briefly in serum-free medium and resuspended at 4 x 107 cells/ml in complete ciprofloxacin-containing medium. Aliquots of cells (300 µl) were briefly preincubated with no more than 30 µg of experimental and vector DNAs and were transfected in 4-mm-gap cuvettes, using a BTX ECM 830 electroporator set to deliver a single 300-V, 10-ms pulse. After 10 min at room temperature, cells were transferred to prewarmed ciprofloxacin-containing complete medium and allowed to recover for 12 to 16 h prior to analysis.
Antibodies and Western blotting.
Three equivalent antibodies against the human CD3
chain were used interchangeably to trigger T-cell activation and complex formation. Purified OKT3 was obtained from Bio-Express Cell Culture Services (West Lebanon, NH), and purified HIT-3a and UCHT1 were obtained from BD Pharmingen. Each antibody performed similarly in our complex formation assays. Western blotting was performed as described previously to confirm the presence or absence of protein expression in the mutant cell lines (48) (see Fig. S1 in the supplemental material). The following antibodies were used: anti-Lck (sc-433) and secondary detection reagents from Santa Cruz Biotechnology, Inc., anti-SLP-76 (AS55-P) from Antibody Solutions, Inc., anti-LAT (06-807) and anti-PLC-
1 (05-163) from Upstate Biotechnology, Inc., and anti-ZAP-70 (610240) from BD Transduction Laboratories, Inc.
Cellular imaging and image analysis. As described previously, complex formation was monitored in Jurkat T-cell lines by using a modified T-cell spreading assay (8). Live images were collected as vertical Z stacks and then subsampled over the plane of the coverslip. Alternately, single z sections were captured over time to improve the rate of image acquisition; in these cases, proper focus was maintained using guide cells with distinguishable fluorescence properties to mark the plane of the coverslip. In studies employing transiently transfected cells, expression levels are heterogeneous. To restrict our analyses to cells expressing physiological levels of protein, we imaged them under fixed conditions, varying only the exposure time. Cells expressing moderate levels of the SLP-76.YFP chimera were identified by comparing the optimal exposure times required to image the experimental cells and control cells stably expressing known levels of the SLP-76 chimera. Only these cells were employed in subsequent analyses. All images were collected using a Perkin-Elmer Ultraview spinning-wheel confocal system mounted on an Axiovert 200 microscope. EGFP and DsRed were detected sequentially using 488-nm and 568-nm laser lines in conjunction with a Perkin-Elmer RGBA dichroic filter and the supplied fluorophore-matched emission filters. CFP and YFP were detected similarly, using 442-nm and 514-nm laser lines in conjunction with a Perkin-Elmer CFP/YFP dichroic filter. Samples were maintained at 37°C. All subsequent image manipulation and analysis were performed using IPLab (Scanalytics).
Functional assays. For CD69 upregulation experiments, 5 x 105 cells/ml were plated in wells containing medium alone, wells containing medium with 20 ng/ml phorbol myristate acetate (PMA), or wells previously coated with C305 antibody, as described previously (49). After overnight culture, cells were stained with APC-conjugated anti-CD69 (BD Pharmingen), and surface expression was analyzed on a FACSCalibur cytometer (BD Biosciences). NF-AT assays were set up in glass-bottomed 96-well plates (Whatman) coated with poly-L-lysine, incubated overnight at 4°C with the indicated dilutions of OKT3 in phosphate-buffered saline, and blocked for 1 h at 37°C with 1% bovine serum albumin in phosphate-buffered saline (8). Cells to be assayed for NF-AT activation were transfected with 15 µg of a composite NF-AT/AP-1 luciferase reporter plasmid and 3 µg/ml of a control Renilla luciferase expression vector, pRL-TK (16). After recovering overnight, transfected cells were plated at 105 cells/well in a total volume of 100 µl. Positive controls were treated with 50 ng/ml PMA and 1 µM ionomycin. After 6 h at 37°C, plates were assayed for luciferase activity by adding 100 µl of SteadyLite reagent (Perkin-Elmer) directly to the wells of the plate. Renilla luciferase activity was assayed in the same wells by adding 25 µl RenLite reagent to each well, as described previously (45). For both assays, plates were read on a Trilux counter (Perkin-Elmer) approximately 15 min after the addition of the relevant reagent. Controls confirmed that there is no cross-reactivity between AP-1 and Renilla luciferase activities assayed in this fashion. All values were normalized to internal Renilla controls and then to the maximal responses observed in the presence of PMA and ionomycin.
| RESULTS |
|---|
|
|
|---|
|
Lck, ZAP-70, LAT, and PLC-
1 have been predicted to play roles in cluster assembly or stabilization, and they play critical roles in T-cell activation. To test whether cluster formation, persistence, or movement correlated with normal activation, we examined Jurkat-derived T-cell lines lacking these proteins (J.CaM1, P116, J.CaM2, and J
1, respectively) (31). The loss and reconstitution of these signaling proteins are confirmed in Fig. S1 in the supplemental material. To quantitate differences in cluster formation, persistence, and movement in these cell lines, we identified moving complexes in maximum-over-time projections, traced individual cluster trajectories in kymographs, and presented the average behavior of these clusters, using composite kymographs and mean translocation plots (see Fig. S2 in the supplemental material). To limit our analyses to cells expressing approximately physiological levels of protein, we identified and analyzed only those cells that expressed moderate levels of SLP-76.YFP, as determined by comparison with a control cell line stably overexpressing known amounts of SLP-76 (see Materials and Methods). Representative maximum-over-time projections (Fig. 2A) reveal that all aspects of cluster formation are compromised in the absence of Lck, ZAP-70, or LAT. Overall, fewer cells formed clusters, and those clusters that did form neither persisted nor translocated (Fig. 2B). These defects are specific to the deficiencies in question, as reconstitution restored normal cluster behavior in these cell lines. Thus, cluster persistence and movement are correlated with effective T-cell activation.
|
Since abortive cluster formation was observed in the Lck-, ZAP-70-, and LAT-deficient cell lines, we hypothesized that a distinct Fyn-dependent pathway might account for residual cluster-nucleating activity. PP2, a drug that inhibits both Lck and Fyn, blocked the formation of SLP-76-containing complexes at doses that prevented the recruitment of ZAP-70 to the TCR (Fig. 2E). This is consistent with a role for Fyn in the formation of the labile SLP-76-containing clusters observed in the absence of Lck, ZAP-70, or LAT.
Although PLC-
1 interacts with multiple components of LAT-nucleated signaling complexes and may participate in cooperative interactions within the complex, SLP-76-containing clusters behaved normally in the PLC-
1-deficient J
1 cell line (Fig. 2A to D) (6, 31). Since these cells are incapable of normal activation, these data indicate that complex formation is insufficient for maximal activation in the absence of an essential downstream effector. Although this formally indicates that PLC-
1 does not play a significant role in cluster stabilization in this model system, the J
1 cell line expresses the highly related protein PLC-
2. This PLC isoform is phosphorylated in response to TCR ligation and may compensate to some degree for the absence of PLC-
1 (24).
Multiple domains of SLP-76 contribute to cluster formation, persistence, and translocation.
To identify the molecular mechanisms regulating the formation, persistence, and translocation of SLP-76-containing clusters, we monitored the behavior of these clusters in SLP-76-deficient Jurkat cells stably reconstituted with EGFP-tagged variants of SLP-76 (Fig. 3A). The primary role in the recruitment of SLP-76 to LAT has been attributed to the Gads-binding motif of SLP-76. Additional protein-protein interaction domains include (i) a triply tyrosine-phosphorylated domain that interacts with the SH2 domains of Vav, Nck, and Itk; (ii) the P1 domain, a 67-amino-acid proline-rich region initially identified as a PLC-
1-binding site; and (iii) the SH2 domain, which binds the adaptor ADAP and the serine/threonine kinase HPK1 (7, 9, 14, 32, 36, 43, 47, 49, 58). To minimize the risk of clonal artifacts, our stable lines were derived as polyclonal populations by high-speed cell sorting and matched for EGFP.SLP-76 expression by flow cytometry and Western blotting (49). These amino-terminally tagged SLP-76 chimeras (EGFP.SLP-76) translocate to the center of the contact surface (Fig. 3B) (49), as originally shown for SLP-76 chimeras tagged at the carboxy terminus (SLP-76.YFP) (10). These clusters traveled approximately 2 µm inward, persisted for approximately 4 min, and achieved speeds of approximately 1 µm/minute (Fig. 3C). In contrast, the assembly, persistence, and movement of clusters were severely defective in all mutant lines (Fig. 3B and C; see Video S2 in the supplemental material). In particular, the P1-deleted (P1) and tyrosine mutant (Y3F) chimeras assembled into clusters that dissipated within 90 seconds, without undergoing significant medial movement, whereas the Gads-binding mutant (G2) and SH2 domain mutant (RK) chimeras were not recruited into clusters at all. Although the tyrosine-phosphorylated domain, the P1 domain, and the SH2 domain are commonly viewed as effector docking sites, our results indicate that these domains play unexpectedly important roles in the assembly, persistence, and movement of SLP-76-containing clusters. We predict that each of the domains tested here contributes molecular interactions that cooperate to stabilize SLP-76-containing clusters.
|
|
|
Multiple domains of Gads contribute to cluster formation and translocation.
The isolated carboxy-terminal SH3 domain of Gads potently inhibited the recruitment of SLP-76 into clusters, indicating that the absent amino-terminal domains of Gads normally play critical roles in cluster formation. Three protein interaction domains have been identified in this region of Gads, including the amino-terminal SH3 domain, an SH2 domain, and a proline-rich linker (3, 32). To identify the Gads domains contributing to cluster formation, we transfected a panel of mCFP-tagged Gads chimeras into our SLP-76.YFP-expressing J14 cells (Fig. 5A; see Fig. S3 in the supplemental material). Wild-type Gads colocalized perfectly with SLP-76 in persistent, mobile clusters (Fig. 5B). Mutation in either the amino-terminal SH3 domain (Gads.N3*) or the proline-rich region (Gads.
Pro) did not affect the recruitment of Gads into clusters, whereas mutation of the carboxy-terminal SH3 domain (Gads.C3*) created a dominant-negative chimera that inhibited the persistence and movement of SLP-76-containing clusters (Fig. 5B). This behavior is analogous to that exhibited by the isolated carboxy-terminal SH3 domain of Gads in Fig. 4D. Unexpectedly, mutation of the SH2 domain, which was expected to play an essential role in cluster formation by linking the Gads chimera with LAT, had no effect on cluster formation or the recruitment of Gads into clusters (Fig. 5B; see Video S4 in the supplemental material). Since considerable biochemical data support the important role of the Gads SH2 domain in T-cell activation, we also examined the behaviors of Gads chimeras containing paired mutations (Fig. 5A). Mutation of both the amino-terminal SH3 domain and the SH2 domain resulted in the generation of a dominant-negative Gads chimera that was not recruited into complexes and inhibited the recruitment of SLP-76 into clusters (Fig. 5C; see Video S5 in the supplemental material). This result confirms that the SH2 domain plays an essential but partially redundant role in cluster formation. The mutation of both SH3 domains created a less potent dominant-negative Gads chimera that was not recruited into clusters but only partially inhibited the recruitment of SLP-76 into clusters (Fig. 5C). In contrast, mutation of the SH2 domain and the carboxy-terminal SH3 domain created an inert Gads chimera that was not recruited into clusters and did not perturb the localization of SLP-76 (Fig. 5C; see Video S6 in the supplemental material). These data reveal an unexpected complexity of Gads interactions. There are at least two functional regions within Gads, namely, the carboxy-terminal SH3 domain, which is sufficient to direct the interaction between Gads and SLP-76, and an amino-terminal region comprising the first SH3 domain and the SH2 domain, which each appear to promote the interaction of Gads with LAT.
|
1. A mutant LAT chimera lacking these tyrosines (LAT.CFP.4YF) remained uniformly distributed in the plasma membrane following TCR ligation, even though the coexpressed SLP-76 chimera, presumably interacting with endogenous LAT, clustered normally (Fig. 6A, bottom row; see Video S8 in the supplemental material). These data indicate that phosphotyrosine-mediated protein-protein interactions drive the clustering of LAT, as we and others have argued previously (10, 15, 21).
|
1 is responsible for the failed assembly of LAT into signaling clusters, we tagged wild-type LAT with a red fluorescent protein. We expressed the resulting chimera, LAT.DsRed, in J14 cell lines stably reconstituted with either the wild-type EGFP.SLP-76 chimera or matched levels of the P1/G2 double-mutant chimera, which cannot bind Gads or PLC-
1. Although the DsRed fluorescent tag induced some nonspecific aggregation of LAT, the LAT.DsRed chimera clearly assembled into clusters with wild-type EGFP.SLP-76 (Fig. 6B, top row). LAT and SLP-76 persisted in these clusters and coordinately moved to a central compartment. Although the LAT.DsRed chimera entered signaling clusters in the P1/G2 mutant line, these clusters were less persistent (not shown) and did not display directed movement (Fig. 6B, bottom row), indicating that the translocation of LAT required its interaction with Gads and SLP-76. Since the LAT chimera behaved in the same manner in the absence of SLP-76 (compare the left and right cells in the bottom row of Fig. 6B), the residual LAT clustering must be independent of SLP-76. These observations indicate that the assembly of LAT into clusters capable of translocation requires SLP-76 but that alternate tyrosine-dependent mechanisms recruit LAT into transient, static clusters. | DISCUSSION |
|---|
|
|
|---|
Fates of SLP-76-containing signaling clusters. In all three imaging systems discussed above, SLP-76-containing clusters are seen to persist, move towards the center of the contact interface, and ultimately diverge from their initiating TCR microclusters. In our study, the SLP-76-containing clusters induced by superantigen move laterally within the contact interface and can be detected within this interface for 20 to 30 min. Although lateral cluster movement and central accumulation were not observed in the superantigen-induced contacts studied by Yokosuka et al., their studies examined SLP-76-containing clusters 30 min after contact formation (59). By this time, the clusters observed in our studies had typically dissipated. Antigen-presenting lipid bilayers induce signaling clusters that colocalize with the TCR in mobile clusters until SLP-76 disappears during its transit towards the center of the contact surface (59). The failure to observe centralized SLP-76-containing clusters on lipid bilayers may result from the failure to detect internalized structures, as the illumination employed in total internal reflection/fluorescence-based studies only penetrates to depths of 50 to 100 nm. Alternately, centralized SLP-76-containing structures may not be observed because of differences in the nature of the responding cell (primary cell versus cell line), the quality of the TCR ligand (pMHC versus superantigen), or the costimulatory molecules presented by the stimulatory surface (lipid bilayer versus intact B cell). Finally, immobilized antibodies induce SLP-76-containing clusters that segregate from initiating TCR microclusters and move towards the center of the contact surface (10). Although this last system, which was employed in these studies, is the only system to give rise to SLP-76-containing clusters that demonstrably persist apart from the TCR, this difference may be due to the artificial immobilization of the TCR by stimulatory antibodies. Although further studies will be required to determine how differences in the methods of stimulation and visualization influence cluster formation and persistence, our observations indicate that SLP-76-containing clusters can persist apart from the TCR and that these clusters are capable of temporarily maintaining their integrity in the absence of continuous interactions with TCR microclusters.
Multiple protein-protein interactions regulate cluster nucleation and persistence. The SLP-76-containing clusters described above are poised to regulate T-cell activation. However, the precise composition of these clusters remains undefined. The studies presented here confirm that the anticipated protein-protein interactions play critical roles within these clusters (i.e., the Gads SH2 domain, the Gads C-SH3 domain, and the Gads-binding G2 site in SLP-76). However, our studies have demonstrated that several protein interaction domains previously thought to function as effector recruitment sites play important roles in the assembly and stabilization of signaling clusters.
Dramatically, the inactivation of the SLP-76 SH2 domain abolishes the recruitment of SLP-76 into clusters, blocks CD69 upregulation, and prevents the activation of NF-AT. Although some studies have indicated a limited role for the SH2 domain, a partially redundant role in cluster nucleation may have been obscured by the constitutive membrane localization of the SLP-76 chimeras used in these studies (4). Additional studies performed with SLP-76-deficient cells stably reconstituted with SH2 domain mutants or Gads-binding-site mutants confirmed that the roles played by these two sites are comparable and essential (38, 58). The critical SH2 domain ligand supporting complex nucleation has not yet been defined. The adaptor ADAP and the serine-threonine kinase HPK1 are likely candidates, as these proteins bind the SLP-76 SH2 domain and are capable of engaging components of the TCR-proximal signaling complex independently of SLP-76 (14, 33, 47). Therefore, multivalent interactions involving SLP-76 and ADAP or HPK1 could stabilize the observed signaling clusters.
The proline-rich P1 domain and the amino-terminal tyrosines of SLP-76 are best known for their effector-binding properties. Nevertheless, both domains are required for persistent cluster formation (38, 49). Given the important role of the P1 domain and the biochemical evidence in favor of a cooperative bridging model in which PLC-
1 links SLP-76 to LAT, we were surprised to find that PLC-
1 is not required for the formation, persistence, or movement of SLP-76-containing clusters (31). Thus, the cooperative interactions reported to recruit PLC-
1 into signaling clusters may not contribute to the overall stability of individual SLP-76-containing clusters. Although PLC-
2 is present in the J
1 line and may compensate for any structural role associated with PLC-
1, our mutational analyses also indicated that the P1 domain contributes to cluster stability and effective T-cell activation (24). Thus, an as yet uncharacterized ligand of the P1 domain is likely to play an important role in cluster stabilization (58). Similarly, we do not yet understand how the amino-terminal tyrosines of SLP-76 contribute to cluster stability, i.e., whether they work through cooperative protein-protein interactions or through the catalytic functions of associated proteins (9, 56, 57). Regardless of how these domains contribute to complex stability, our observations emphasize the utility of imaging approaches that directly evaluate cluster formation as a complement to traditional biochemical and functional approaches.
Cooperative interactions stabilize SLP-76-containing clusters. Cooperative models of complex formation have been invoked to explain the requirement that several distinct phosphorylation sites be present on each LAT molecule (31). Our observations are inconsistent with common linear models of complex formation. First, four distinct regions within SLP-76 contribute to cluster formation and persistence, indicating that these regions cooperate to stabilize signaling complexes. Second, SLP-76 controls the recruitment of Gads into clusters. Finally, Gads does not act as a simple bifunctional bridge between LAT and SLP-76. Instead, the amino-terminal SH3 domain and the SH2 domain of Gads are partially redundant with respect to cluster formation and cooperate to recruit Gads into LAT-nucleated clusters. These data support a model in which LAT, Gads, and SLP-76 act as a core signaling cluster stabilized by multiple cooperative interactions among these proteins and additional cluster constituents (6).
Defective signaling clusters are rapidly terminated. While certain alterations abolish cluster formation altogether, diverse perturbations of the SLP-76-containing clusters result in the dissociation of these structures within 90 to 120 seconds, prior to the initiation of medial cluster movement. This effect has been observed in cells lacking Lck, ZAP-70, or LAT, in cells expressing SLP-76 mutants affected in either the amino-terminal tyrosines or the P1 domain, and in cells expressing dominant-negative variants of Gads. The similarity of these behaviors suggests that the failure to persist is regulated by a conserved inhibitory mechanism triggered in response to partial signaling, as predicted by modified versions of the kinetic proofreading model (51). We speculate that this inhibitory process is dampened in cells that assemble mature SLP-76-containing clusters.
Implications of cooperative cluster formation. We have demonstrated a strong relationship between the persistence of cooperatively stabilized SLP-76-containing signaling clusters and optimal T-cell activation (Table 1). We predict that this relationship arises because cooperative cluster stabilization serves several critical needs. First, cooperative interactions may support cluster formation and antagonize cluster dissociation by enabling the assembly of high-avidity macromolecular complexes from multiple low-affinity protein-protein interactions. In this manner, cooperative interactions may increase antigen sensitivity and sharpen the thresholds regulating the discrimination of antigen from self. Second, the diverse interactions within a cooperatively assembled cluster may facilitate the integration of multiple costimulatory or suppressive inputs by providing multiple targets for the modulation of T-cell responses. Finally, highly favorable cooperative interactions may constrain the topology of mature signaling clusters, enabling the selective recruitment of adaptors to LAT in vivo (13, 22, 31, 62). A better understanding of these complex intermolecular interactions will enable the modulation of immune responses by endogenous signaling pathways and by targeted pharmacologic agents.
| ACKNOWLEDGMENTS |
|---|
This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and by grants from the National Institutes of Health (F32-DK09969 to A.L.S. and P01-CA93615 to M.S.J. and G.A.K.). S.C.B. was a fellow of the Cancer Research Institute. D.I.H. was a Howard Hughes Medical Institute-National Institutes of Health research scholar.
| FOOTNOTES |
|---|
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
S.C.B. and A.L.S. contributed equally to this work. ![]()
Present address: Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD 21287. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Barda-Saad, M., A. Braiman, R. Titerence, S. C. Bunnell, V. A. Barr, and L. E. Samelson. 2005. Dynamic molecular interactions linking the T cell antigen receptor to the actin cytoskeleton. Nat. Immunol. 6:80-89.[CrossRef][Medline]
3. Berry, D. M., P. Nash, S. K. Liu, T. Pawson, and C. J. McGlade. 2002. A high-affinity Arg-X-X-Lys SH3 binding motif confers specificity for the interaction between Gads and SLP-76 in T cell signaling. Curr. Biol. 12:1336-1341.[CrossRef][Medline]
4. Boerth, N. J., J. J. Sadler, D. E. Bauer, J. L. Clements, S. M. Gheith, and G. A. Koretzky. 2000. Recruitment of SLP-76 to the membrane and glycolipid-enriched membrane microdomains replaces the requirement for linker for activation of T cells in T cell receptor signaling. J. Exp. Med. 192:1047-1058.
5. Boniface, J. J., J. D. Rabinowitz, C. Wulfing, J. Hampl, Z. Reich, J. D. Altman, R. M. Kantor, C. Beeson, H. M. McConnell, and M. M. Davis. 1998. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity 9:459-466.[CrossRef][Medline]
6. Braiman, A., M. Barda-Saad, C. L. Sommers, and L. E. Samelson. 2006. Recruitment and activation of PLCgamma1 in T cells: a new insight into old domains. EMBO J. 25:774-784.[CrossRef][Medline]
7. Bubeck Wardenburg, J., R. Pappu, J. Y. Bu, B. Mayer, J. Chernoff, D. Straus, and A. C. Chan. 1998. Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76. Immunity 9:607-616.[CrossRef][Medline]
8. Bunnell, S. C., V. A. Barr, C. L. Fuller, and L. E. Samelson. 2003. High-resolution multicolor imaging of dynamic signaling complexes in T cells stimulated by planar substrates. Sci. STKE 2003:PL8.[Medline]
9. Bunnell, S. C., M. Diehn, M. B. Yaffe, P. R. Findell, L. C. Cantley, and L. J. Berg. 2000. Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. J. Biol. Chem. 275:2219-2230.
10. Bunnell, S. C., D. I. Hong, J. R. Kardon, T. Yamazaki, C. J. McGlade, V. A. Barr, and L. E. Samelson. 2002. T cell receptor ligation induces the formation of dynamically regulated signaling assemblies. J. Cell Biol. 158:1263-1275.
11. Bunnell, S. C., V. Kapoor, R. P. Trible, W. Zhang, and L. E. Samelson. 2001. Dynamic actin polymerization drives T cell receptor-induced spreading: a role for the signal transduction adaptor LAT. Immunity 14:315-329.[CrossRef][Medline]
12. Campi, G., R. Varma, and M. L. Dustin. 2005. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J. Exp. Med. 202:1031-1036.
13. Cho, S., C. A. Velikovsky, C. P. Swaminathan, J. C. Houtman, L. E. Samelson, and R. A. Mariuzza. 2004. Structural basis for differential recognition of tyrosine-phosphorylated sites in the linker for activation of T cells (LAT) by the adaptor Gads. EMBO J. 23:1441-1451.[CrossRef][Medline]
14. da Silva, A. J., Z. Li, C. de Vera, E. Canto, P. Findell, and C. E. Rudd. 1997. Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. Proc. Natl. Acad. Sci. USA 94:7493-7498.
15. Douglass, A. D., and R. D. Vale. 2005. Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell 121:937-950.[CrossRef][Medline]
16. Durand, D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715-1724.
17. Fang, N., D. G. Motto, S. E. Ross, and G. A. Koretzky. 1996. Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity. J. Immunol. 157:3769-3773.[Abstract]
18. Freiberg, B. A., H. Kupfer, W. Maslanik, J. Delli, J. Kappler, D. M. Zaller, and A. Kupfer. 2002. Staging and resetting T cell activation in SMACs. Nat. Immunol. 3:911-917.[CrossRef][Medline]
19. Grakoui, A., S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285:221-227.
20. Hailman, E., W. R. Burack, A. S. Shaw, M. L. Dustin, and P. M. Allen. 2002. Immature CD4(+)CD8(+) thymocytes form a multifocal immunological synapse with sustained tyrosine phosphorylation. Immunity 16:839-848.[CrossRef][Medline]
21. Harder, T., and M. Kuhn. 2000. Selective accumulation of raft-associated membrane protein LAT in T cell receptor signaling assemblies. J. Cell Biol. 151:199-208.
22. Houtman, J. C., Y. Higashimoto, N. Dimasi, S. Cho, H. Yamaguchi, B. Bowden, C. Regan, E. L. Malchiodi, R. Mariuzza, P. Schuck, E. Appella, and L. E. Samelson. 2004. Binding specificity of multiprotein signaling complexes is determined by both cooperative interactions and affinity preferences. Biochemistry 43:4170-4178.[CrossRef][Medline]
23. Huppa, J. B., M. Gleimer, C. Sumen, and M. M. Davis. 2003. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4:749-755.[CrossRef][Medline]
24. Irvin, B. J., B. L. Williams, A. E. Nilson, H. O. Maynor, and R. T. Abraham. 2000. Pleiotropic contributions of phospholipase C-
1 (PLC-
1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-
1-deficient Jurkat T-cell line. Mol. Cell. Biol. 20:9149-9161.
25. Krogsgaard, M., Q. J. Li, C. Sumen, J. B. Huppa, M. Huse, and M. M. Davis. 2005. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature 434:238-243.[CrossRef][Medline]
26. Krummel, M. F., and M. M. Davis. 2002. Dynamics of the immunological synapse: finding, establishing and solidifying a connection. Curr. Opin. Immunol. 14:66-74.[CrossRef][Medline]
27. Krummel, M. F., M. D. Sjaastad, C. Wulfing, and M. M. Davis. 2000. Differential clustering of CD4 and CD3zeta during T cell recognition. Science 289:1349-1352.
28. Lee, K. H., A. R. Dinner, C. Tu, G. Campi, S. Raychaudhuri, R. Varma, T. N. Sims, W. R. Burack, H. Wu, J. Wang, O. Kanagawa, M. Markiewicz, P. M. Allen, M. L. Dustin, A. K. Chakraborty, and A. S. Shaw. 2003. The immunological synapse balances T cell receptor signaling and degradation. Science 302:1218-1222.
29. Lee, K. H., A. D. Holdorf, M. L. Dustin, A. C. Chan, P. M. Allen, and A. S. Shaw. 2002. T cell receptor signaling precedes immunological synapse formation. Science 295:1539-1542.
30. Lin, J., M. J. Miller, and A. S. Shaw. 2005. The c-SMAC: sorting it all out (or in). J. Cell Biol. 170:177-182.
31. Lin, J., and A. Weiss. 2001. Identification of the minimal tyrosine residues required for linker for activation of T cell function. J. Biol. Chem. 276:29588-29595.
32. Liu, S. K., N. Fang, G. A. Koretzky, and C. J. McGlade. 1999. The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Curr. Biol. 9:67-75.[CrossRef][Medline]
33. Liu, S. K., C. A. Smith, R. Arnold, F. Kiefer, and C. J. McGlade. 2000. The adaptor protein Gads (Grb2-related adaptor downstream of Shc) is implicated in coupling hemopoietic progenitor kinase-1 to the activated TCR. J. Immunol. 165:1417-1426.
34. McKeithan, T. W. 1995. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA 92:5042-5046.
35. Mossman, K. D., G. Campi, J. T. Groves, and M. L. Dustin. 2005. Altered TCR signaling from geometrically repatterned immunological synapses. Science 310:1191-1193.
36. Musci, M. A., L. R. Hendricks-Taylor, D. G. Motto, M. Paskind, J. Kamens, C. W. Turck, and G. A. Koretzky. 1997. Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases. J. Biol. Chem. 272:11674-11677.
37. Musci, M. A., D. G. Motto, S. E. Ross, N. Fang, and G. A. Koretzky. 1997. Three domains of SLP-76 are required for its optimal function in a T cell line. J. Immunol. 159:1639-1647.[Abstract]
38. Myung, P. S., G. S. Derimanov, M. S. Jordan, J. A. Punt, Q. H. Liu, B. A. Judd, E. E. Meyers, C. D. Sigmund, B. D. Freedman, and G. A. Koretzky. 2001. Differential requirement for SLP-76 domains in T cell development and function. Immunity 15:1011-1026.[CrossRef][Medline]
39. Negulescu, P. A., T. B. Krasieva, A. Khan, H. H. Kerschbaum, and M. D. Cahalan. 1996. Polarity of T cell shape, motility, and sensitivity to antigen. Immunity 4:421-430.[CrossRef][Medline]
40. O'Keefe, J. P., K. Blaine, M. L. Alegre, and T. F. Gajewski. 2004. Formation of a central supramolecular activation cluster is not required for activation of naive CD8+ T cells. Proc. Natl. Acad. Sci. USA 101:9351-9356.
41. O'Keefe, J. P., and T. F. Gajewski. 2005. Cutting edge: cytotoxic granule polarization and cytolysis can occur without central supramolecular activation cluster formation in CD8+ effector T cells. J. Immunol. 175:5581-5585.
42. Purtic, B., L. A. Pitcher, N. S. van Oers, and C. Wulfing. 2005. T cell receptor (TCR) clustering in the immunological synapse integrates TCR and costimulatory signaling in selected T cells. Proc. Natl. Acad. Sci. USA 102:2904-2909.
43. Raab, M., A. J. da Silva, P. R. Findell, and C. E. Rudd. 1997. Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2. Immunity 6:155-164.[CrossRef][Medline]
44. Richie, L. I., P. J. Ebert, L. C. Wu, M. F. Krummel, J. J. Owen, and M. M. Davis. 2002. Imaging synapse formation during thymocyte selection: inability of CD3zeta to form a stable central accumulation during negative selection. Immunity 16:595-606.[CrossRef][Medline]
45. Routledge, E. J., R. White, M. G. Parker, and J. P. Sumpter. 2000. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J. Biol. Chem. 275:35986-35993.
46. Samelson, L. E. 2002. Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu. Rev. Immunol. 20:371-394.[CrossRef][Medline]
47. Sauer, K., J. Liou, S. B. Singh, D. Yablonski, A. Weiss, and R. M. Perlmutter. 2001. Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes. J. Biol. Chem. 276:45207-45216.
48. Seminario, M. C., P. Precht, S. C. Bunnell, S. E. Warren, C. M. Morris, D. Taub, and R. L. Wange. 2004. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt. Eur. J. Immunol. 34:3165-3175.[CrossRef][Medline]
49. Singer, A. L., S. C. Bunnell, A. E. Obstfeld, M. S. Jordan, J. N. Wu, P. S. Myung, L. E. Samelson, and G. A. Koretzky. 2004. Roles of the proline-rich domain in SLP-76 subcellular localization and T cell function. J. Biol. Chem. 279:15481-15490.
50. Stauffer, T. P., and T. Meyer. 1997. Compartmentalized IgE receptor-mediated signal transduction in living cells. J. Cell Biol. 139:1447-1454.
51. Stefanova, I., B. Hemmer, M. Vergelli, R. Martin, W. E. Biddison, and R. N. Germain. 2003. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 4:248-254.[CrossRef][Medline]
52. Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585-593.[CrossRef][Medline]
53. Valitutti, S., M. Dessing, K. Aktories, H. Gallati, and A. Lanzavecchia. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J. Exp. Med. 181:577-584.
54. Wilson, B. S., J. R. Pfeiffer, and J. M. Oliver. 2000. Observing Fc
RI signaling from the inside of the mast cell membrane. J. Cell Biol. 149:1131-1142.
55. Wilson, B. S., J. R. Pfeiffer, Z. Surviladze, E. A. Gaudet, and J. M. Oliver. 2001. High resolution mapping of mast cell membranes reveals primary and secondary domains of Fc(epsilon)RI and LAT. J. Cell Biol. 154:645-658.
56. Wu, J., D. G. Motto, G. A. Koretzky, and A. Weiss. 1996. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4:593-602.[CrossRef][Medline]
57. Wunderlich, L., A. Farago, J. Downward, and L. Buday. 1999. Association of Nck with tyrosine-phosphorylated SLP-76 in activated T lymphocytes. Eur. J. Immunol. 29:1068-1075.[CrossRef][Medline]
58. Yablonski, D., T. Kadlecek, and A. Weiss. 2001. Identification of a phospholipase C-
1 (PLC-
1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-
1 and NFAT. Mol. Cell. Biol. 21:4208-4218.
59. Yokosuka, T., K. Sakata-Sogawa, W. Kobayashi, M. Hiroshima, A. Hashimoto-Tane, M. Tokunaga, M. L. Dustin, and T. Saito. 2005. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat. Immunol. 6:1253-1262.[CrossRef][Medline]
60. Zacharias, D. A., J. D. Violin, A. C. Newton, and R. Y. Tsien. 2002. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296:913-916.
61. Zal, T., M. A. Zal, and N. R. Gascoigne. 2002. Inhibition of T cell receptor-coreceptor interactions by antagonist ligands visualized by live FRET imaging of the T-hybridoma immunological synapse. Immunity 16:521-534.[CrossRef][Medline]
62. Zhang, W., R. P. Trible, M. Zhu, S. K. Liu, C. J. McGlade, and L. E. Samelson. 2000. Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell antigen receptor-mediated signaling. J. Biol. Chem. 275:23355-23361.